RxDoctor Payments Data

Khushpreet Cheema, PA

Physician Assistant · Camp Hill, PANPI 1629489182

Payments from drug & device makers

$4,064in general payments, 2019–2025

Across 230 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$626
  • Johnson & Johnson$527
  • Regeneron Healthcare Solutions, Inc.$441
  • AbbVie$440
  • Madrigal Pharmaceuticals$415
  • Takeda Pharmaceuticals U.S.A., Inc.$308
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$4,01399%
  • Education$511%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,064 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$49,003
Medicare patients
470
Services billed
561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide71$79,870
Dexlansoprazole DrDexlansoprazole69$22,269
Mesalamine27$17,141
Famotidine416$8,706
Lubiprostone27$4,582
Pantoprazole Sodium333$4,338
Sucralfate35$3,157
CholestyramineCholestyramine (With Sugar)56$2,745
SutabSod Sulf/Pot Chloride/Mag Sulf18$2,660
Esomeprazole Magnesium44$2,388
Omeprazole157$2,039
Dicyclomine Hcl38$1,152
Colesevelam Hcl28$965
Lansoprazole24$516
Ondansetron OdtOndansetron21$418

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$440$79,87071 claims
Braintree Laboratories, Inc.Sutab$191$2,66018 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Camp Hill

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →